Greenwich LifeSciences (GLSI) Current Assets (2019 - 2025)
Greenwich LifeSciences (GLSI) posted Current Assets of $6.2 million for Q4 2025, up 50.98% on a QoQ basis from $4.1 million in Q4 2024, and up 50.98% year-over-year from $4.1 million in Q4 2024.
Greenwich LifeSciences (GLSI) Current Assets (2019 - 2025) Analysis & Trends
Greenwich LifeSciences' Current Assets history runs 5 years deep, the most recent figure standing at $6.2 million for Q4 2025.
- Quarterly Current Assets rose 50.98% year-over-year to $6.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.2 million (up 50.98% YoY) and the FY2025 annual result came in at $6.2 million, up 50.98% from the prior year.
- Current Assets was $6.2 million for Q4 2025 at Greenwich LifeSciences, up from $4.1 million in the prior quarter.
- Across five years, Current Assets topped out at $30.4 million in Q1 2021 and bottomed at $4.1 million in Q4 2024.
- A 3-year average of $19.9 million and a median of $28.9 million in 2021 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2021 — Current Assets surged 361.98% — and 2025, when it surged 50.98%.
- Greenwich LifeSciences' Current Assets stood at $28.9 million in 2021, then tumbled by 85.84% to $4.1 million in 2024, then soared by 50.98% to $6.2 million in 2025.
- Business Quant data shows GLSI's Current Assets at $6.2 million in Q4 2025, $4.1 million in Q4 2024, and $28.9 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Greenwich LifeSciences | 178.53 Mn | 178.53 Mn | - | 6.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.18 Mn |
| Dec 31, 2024 | 4.09 Mn |
| Sep 30, 2021 | 28.91 Mn |
| Jun 30, 2021 | 29.80 Mn |
| Mar 31, 2021 | 30.40 Mn |
| Dec 31, 2020 | 28.66 Mn |
| Sep 30, 2020 | 6.26 Mn |
| Dec 31, 2019 | 6,835.00 |